Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XZ2P
|
||||
Former ID |
DNC007021
|
||||
Drug Name |
KSP-BCS-1-alpha-CHF2-20-epi-22-oxabishomo-26-OH
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528563] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H48F2O3
|
||||
Canonical SMILES |
CCC(CC)(CCCOC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)C(F)F)O)<br />C)O
|
||||
InChI |
1S/C30H48F2O3/c1-6-30(34,7-2)16-9-17-35-21(4)26-13-14-27-22(10-8-15-29(26,27)5)11-12-23-18-24(33)19-25(20(23)3)28(31)32/h11-12,21,24-28,33-34H,3,6-10,13-19H2,1-2,4-5H3/b22-11+,23-12-/t21-,24-,25+,26-,27+,29-/m1/s1
|
||||
InChIKey |
JHEXIWJRXZGBMA-AFLZJIMUSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vitamin D receptor | Target Info | Inhibitor | [528563] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PANTHER Pathway | Vitamin D metabolism and pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.